Ocrelizumab: A New Therapeutic Paradigm for Multiple Sclerosis

被引：2
|
作者：
Chin, Peter [1 ]
Chan, Andrew C. [2 ]
机构：
[1] Genentech Inc, Med Affairs, One DNA Way, San Francisco, CA 94080 USA
[2] Genentech Inc, Res, One DNA Way, San Francisco, CA 94080 USA
来源：
BIOCHEMISTRY | 2018年 / 57卷 / 05期
关键词：
RITUXIMAB; PLACEBO;
D O I：
10.1021/acs.biochem.7b00796
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 476
页数：3
相关论文
共 50 条
  • [41] Multiple Sclerosis - New Therapeutic Options in Sight
    Ameri, Abdol A.
    NERVENHEILKUNDE, 2012, 31 (12) : 960 - 961
  • [42] Immunoadsorption - a new therapeutic possibility for multiple sclerosis?
    Schneidewind, JM
    Winkler, R
    Ramlow, W
    Tiess, M
    Hertel, U
    Sehland, D
    TRANSFUSION SCIENCE, 1998, 19 : 59 - 63
  • [43] Ocrelizumab becomes the first approved treatment for multiple sclerosis
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (05) : 968 - 968
  • [44] Switching from natalizumab to ocrelizumab in patients with multiple sclerosis
    Levin, Seth N.
    Ezuma, Chimere
    Levine, Libby
    Vargas, Wendy S.
    Farber, Rebecca S.
    De Jager, Philip L.
    Riley, Claire S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (14) : 1964 - 1965
  • [45] Effect of ocrelizumab on rates of retinal atrophy in multiple sclerosis
    McCormack, Brenna
    Ezzedin, Omar
    Doosti, Rozita
    Bacchetti, Anna
    Moussa, Hussein
    Lambe, Jeffrey
    Filippatou, Angeliki
    Vasileiou, Eleni
    Ehrhardt, Henrik
    Kalaitzidis, Grigorios
    Pellegrini, Nicole
    Kim, Anna
    Ecoff, Kaitlyn
    Ahmadi, Gelareh
    Otero-Duran, Gabriel
    Bonair, Devon
    Johnson, Evan
    Lawrence, Elle
    Lievers, Ernest
    Davis, Simidele
    Park, Sooyeon
    Inserra, Madeline
    Murphy, Olwen
    Newsome, Scott
    Fitzgerald, Kathryn
    Sotirchos, Elias
    Calabresi, Peter
    Saidha, Shiv
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 570 - 571
  • [46] The Impact Of Ocrelizumab On Paramagnetic Rim Lesions In Multiple Sclerosis
    Markowitz, Kimberly
    Safi, Neha Vijayvargiya
    Kaunzner, Ulrike W.
    Luu, Ha
    Wang, Yi
    Rua, Sandra Hurtado
    Thanh Nguyen
    Gauthier, Susan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 275 - 275
  • [47] New therapeutic strategies in multiple sclerosis.
    Berger, E
    Rumbach, L
    REVUE DE MEDECINE INTERNE, 1999, 20 : 346S - 350S
  • [48] The meninges: new therapeutic targets for multiple sclerosis
    Russi, Abigail E.
    Brown, Melissa A.
    TRANSLATIONAL RESEARCH, 2015, 165 (02) : 255 - 269
  • [49] NEW THERAPEUTIC OPTIONS IN THE TREATMENT OF MULTIPLE SCLEROSIS
    Barun, B.
    Brinar, V.
    NEUROLOGIA CROATICA, 2008, 57 (1-2): : 23 - 34
  • [50] Statins in multiple sclerosis: a new therapeutic option?
    Neuhaus, O
    Archelos, JJ
    Hartung, HP
    MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (05) : 429 - 430
12345